REQUEST A DEMO
Total
USD $0.00
Search more companies

Ajanta Pharma Philippines, Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Ajanta Pharma Philippines, Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The company is primarily engaged in the development, manufacture, and marketing of premium pharmaceutical products worldwide. Operations & branches: at the address, 1702 axa life center 1286 sen. Gil puyat avenue corner tindalo street san antonio village, makati city, 1203 metro manila, we find the registered seat and seat of operations.

Headquarters
1286, Gil Puyat Ave.
City Of Makati; Fourth District, National Capital Region (Ncr);

Contact Details: Purchase the Ajanta Pharma Philippines, Inc. report to view the information.

Website: http://www.ajantapharma.com.ph/

Basic Information
Total Employees:
Purchase the Ajanta Pharma Philippines, Inc. report to view the information.
Financial Auditors:
Purchase the Ajanta Pharma Philippines, Inc. report to view the information.
Incorporation Date:
April 11, 2008
Key Executives
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Non-Executive Director
Purchase this report to view the information.
President;Chairman
Purchase this report to view the information.
Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ajanta Pharma Philippines, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
2.07%
Total operating revenue
1.57%
Net Profit (Loss) for the Period
-17.94%
Total Assets
-10.54%
Total Equity
53.63%
Net Profit Margin
-1.75%
Return on Equity (ROE)
-20.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?